Sanofi Launches Cancer Treatment
Posted in Learn forex trading @ Fri, 30 Jul 2010 00:03:02 +0200
Sanofi-Aventis (NYSE:SNY) recently announced the launch of its oncology drug, Jevtana (cabazitaxel), in the US. The product launch comes a month after the company gained approval from the US Food and Drug Administration (FDA) for the use of Jevtana in combination with prednisone for the treatment of metastatic hormone-refractory prostate cancer (mHRPC) patients who were ...
- ECRI Watch: Be Prepared For A Shocker!
- Gold Poised For A Bullish Breakout
- Private-Sector Jobs Increase For The 7th Month, First Time Since 2007; +763,00 Jobs This Year
- Colombia: World’s #1 Stock Market
- Norfolk Initiated At Neutral
- WSJ Interactive Graph Of The Great Mancession
- MiFi Enters Comcast Network
- Earnings Scorecard: BHP Billiton
- Jacobs Wins Engineering Contract
- Valspar Downgraded
- PDLI Gives Third-Quarter Outlook
- Citrix Penetrates Indian Market
- Job Losses Beat Expectations
- CFTC Decision On Retail Forex Trading Effective As Of October 18, 2010
- Bull Of The Day: Cummins, Inc. (CMI)
- Rating Action On CINF
- Regency Centers Acquires Mall
- Pat Dorsey: Competitive Advantages For Superior Companies
- BMC Software Wins Telecom Deal
- Rosie: Dodging A Bullet, Yes – Out Of The Woods, No